185 related articles for article (PubMed ID: 18513434)
61. [Detecting MUC-1 mRNA for diagnosing peripheral blood micro-metastasis in non-small cell lung cancer patients].
Liu XQ; Ren HX; Wu ZP
Ai Zheng; 2008 Dec; 27(12):1267-70. PubMed ID: 19079991
[TBL] [Abstract][Full Text] [Related]
62. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
Tang XP; Li J; Yu LC; Chen YC; Shi SB; Zhu LR; Chen P
Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
[TBL] [Abstract][Full Text] [Related]
63. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
64. A proliferation-inducing ligand: a new biomarker for non-small cell lung cancer.
Sun B; Wang H; Wang X; Huang H; Ding W; Jing R; Shi G; Zhu L
Exp Lung Res; 2009 Aug; 35(6):486-500. PubMed ID: 19842833
[TBL] [Abstract][Full Text] [Related]
65. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
[TBL] [Abstract][Full Text] [Related]
66. [The diagnostic value of quantitative measurement of a proliferation-inducing ligand mRNA in sputum samples from lung cancer patients].
Sun BL; Zhu L; Ding WF; Jing RR; Chu SP; Wang HM
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Mar; 32(3):182-7. PubMed ID: 19575936
[TBL] [Abstract][Full Text] [Related]
67. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
[TBL] [Abstract][Full Text] [Related]
68. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
69. An accurate and rapid detection of lymph node metastasis in non-small cell lung cancer patients based on one-step nucleic acid amplification assay.
Inoue M; Hiyama K; Nakabayashi K; Morii E; Minami M; Sawabata N; Shintani Y; Nakagiri T; Susaki Y; Maeda J; Higashiyama M; Okami J; Yoshida Y; Ding J; Otomo Y; Okumura M
Lung Cancer; 2012 Dec; 78(3):212-8. PubMed ID: 23026640
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
Lai RS; Chen CC; Lee PC; Lu JY
Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
[TBL] [Abstract][Full Text] [Related]
71. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
72. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Zhou J; Nong L; Wloch M; Cantor A; Mulshine JL; Tockman MS
Lung Cancer; 2001 Dec; 34(3):341-50. PubMed ID: 11714531
[TBL] [Abstract][Full Text] [Related]
73. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
[TBL] [Abstract][Full Text] [Related]
74. Serum Fork-Head Box D3 (FOXD3) Expression Is Down-Regulated in and Associated with Diagnosis of Patients with Non-Small Cell Lung Cancer.
Xu BN; Zhang L; Zhang DD; Song CY; Tian DL; Jiang WJ
Med Sci Monit; 2018 Dec; 24():9504-9508. PubMed ID: 30596382
[TBL] [Abstract][Full Text] [Related]
75. Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.
Yamamoto O; Takahashi H; Hirasawa M; Chiba H; Shiratori M; Kuroki Y; Abe S
Respir Med; 2005 Sep; 99(9):1164-74. PubMed ID: 16085219
[TBL] [Abstract][Full Text] [Related]
76. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
[TBL] [Abstract][Full Text] [Related]
77. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
[TBL] [Abstract][Full Text] [Related]
78. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
79. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M
Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121
[TBL] [Abstract][Full Text] [Related]
80. Combination of multiple gene markers to detect circulating tumor cells in the peripheral blood of patients with non-small cell lung cancer using real-time PCR.
Ding M; Li X; Qiu T
Genet Mol Res; 2015 Oct; 14(4):13033-40. PubMed ID: 26505456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]